日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Capivasertib-Induced Diabetes Successfully Managed With Insulin-Independent Glucose-Lowering Agents: A Case Report

卡帕替尼诱发糖尿病采用非胰岛素依赖型降糖药成功控制：病例报告

期刊:Diabetes-Metabolism Research and Reviews
影响因子:6
doi:10.1002/dmrr.1014
Babaya, Naru; Yu, Liping; Miao, Dongmei; Wang, Jian; Rewers, Marian; Nakayama, Maki; Liu, Edwin; Barker, Jennifer M; Eisenbarth, George S; Kakkar, Nidhi; KY, Haris; Gupta, Sunita; Ramasamy, Pavithra; Ghosh, Sujoy; Urs, Aadithya B; Takeda, Ysutaka; Tsuyama, Mariko; Haba, Yusuke; Inokuchi, Masafumi; Kumashiro, Naoki
代谢
糖尿病
免疫/内分泌
发表日期：2026
文献求助 收藏

Capivasertib-Induced Diabetes Successfully Managed With Insulin-Independent Glucose-Lowering Agents: A Case Report

卡帕替尼诱发糖尿病采用非胰岛素依赖型降糖药成功控制：病例报告

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.105623
Takeda, Ysutaka; Tsuyama, Mariko; Haba, Yusuke; Inokuchi, Masafumi; Kumashiro, Naoki
免疫/内分泌
代谢
糖尿病
发表日期：2026
文献求助 收藏

Comparison of the effects of pemafibrate and omega-3 fatty acid ethyl on fatty liver index in patients with dyslipidemia treated with statin: a sub-analysis from the PROUD48 study

比较培马贝特和ω-3脂肪酸乙酯对接受他汀类药物治疗的血脂异常患者脂肪肝指数的影响：PROUD48研究的亚组分析

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1549687
Takeda, Yasutaka; Furuhashi, Masato; Sakuma, Ichiro; Hiramitsu, Shinya; Okada, Mizuho; Ueda, Shinichiro; Kumashiro, Naoki; Sakurai, Masaru
脂肪肝
心血管
代谢
发表日期：2025
文献求助 收藏

Empagliflozin reduces liver fibrosis by restoring catechol-O-methyltransferase activity associated with magnesium levels.

恩格列净通过恢复与镁水平相关的儿茶酚-O-甲基转移酶活性来减少肝纤维化

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-12813-x
Hayashi Yoshihiro, Kawakita Emi, Kumashiro Naoki, Iijima Hiroshi, Koya Daisuke, Kanasaki Keizo
其它
发表日期：2025
文献求助 收藏

Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background

未使用助眠药物的2型糖尿病患者主观睡眠质量的变化：一项基于年龄和临床背景的横断面研究

期刊:Diabetology International
影响因子:1.2
doi:10.1007/s13340-021-00516-3
Yoshikawa, Fukumi; Kumashiro, Naoki; Shigiyama, Fumika; Miyagi, Masahiko; Ando, Yasuyo; Uchino, Hiroshi; Hirose, Takahisa
糖尿病
代谢
发表日期：2022
文献求助 收藏

A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study

一项前瞻性随机研究，比较恩格列净与西格列汀对早期 2 型糖尿病患者心脏脂肪堆积、心脏功能和心脏代谢的影响：ASSET 研究

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-021-01228-3
Hiruma, Shigenori; Shigiyama, Fumika; Hisatake, Shinji; Mizumura, Sunao; Shiraga, Nobuyuki; Hori, Masaaki; Ikeda, Takanori; Hirose, Takahisa; Kumashiro, Naoki
SET
糖尿病
代谢
发表日期：2021
文献求助 收藏

Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well-controlled type 2 diabetes: A 24-week randomized controlled trial

在血糖控制良好的 2 型糖尿病患者中，使用卡格列净或利拉鲁肽简化复杂胰岛素治疗方案：一项为期 24 周的随机对照试验

期刊:Journal of Diabetes Investigation
影响因子:3
doi:10.1111/jdi.13533
Ando, Yasuyo; Shigiyama, Fumika; Hirose, Takahisa; Kumashiro, Naoki
代谢
糖尿病
免疫/内分泌
发表日期：2021
文献求助 收藏

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)

达格列净与西格列汀对日本 2 型糖尿病患者心血管代谢危险因素的疗效比较：一项前瞻性随机研究（DIVERSITY-CVR）

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-019-0977-z
Fuchigami, Ayako; Shigiyama, Fumika; Kitazawa, Toru; Okada, Yosuke; Ichijo, Takamasa; Higa, Mariko; Hiyoshi, Toru; Inoue, Ikuo; Iso, Kaoru; Yoshii, Hidenori; Hirose, Takahisa; Kumashiro, Naoki
糖尿病
代谢
发表日期：2020
文献求助 收藏

Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium-glucose cotransporter 2 inhibitor: A randomized, open-label, prospective study

钠-葡萄糖协同转运蛋白2抑制剂可降低2型糖尿病患者的胰岛素剂量，从而维持空腹血糖氧化和餐后脂质氧化水平：一项随机、开放标签、前瞻性研究

期刊:Journal of Diabetes Investigation
影响因子:3
doi:10.1111/jdi.12994
Kanazawa, Ken; Uchino, Hiroshi; Shigiyama, Fumika; Igarashi, Hiroyuki; Ikehara, Kayoko; Yoshikawa, Fukumi; Usui, Shuki; Miyagi, Masahiko; Yoshino, Hiroshi; Ando, Yasuyo; Kumashiro, Naoki; Hirose, Takahisa
代谢
糖尿病
免疫/内分泌
发表日期：2019
文献求助 收藏

Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin's Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes

ASSET 研究的理论依据和设计：一项前瞻性随机研究，比较恩格列净与西格列汀对 2 型糖尿病患者心脏脂肪堆积/功能的影响

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-019-0640-4
Shigiyama, Fumika; Hiruma, Shigenori; Hisatake, Shinji; Shiraga, Nobuyuki; Ikeda, Takanori; Hirose, Takahisa; Kumashiro, Naoki
SET
糖尿病
代谢
发表日期：2019
文献求助 收藏